Clinical Trials Logo

Clinical Trial Summary

This research responds to NHTSA's request with a proposal to increase our understanding of smoked cannabis' (CNB's) acute effects on driving-relevant cognition and simulated driving performance, the persistence of these deficits over the hours after use, and the influence of prior experience with CNB on these effects. This extension study will aim to further investigate marijuana impaired behavior, using a similar design to our previous NHTSA Examine the Feasibility of a Standardized Field Test for Marijuana Impairment and the prior NIDA Neuroscience of Marijuana-Impaired Driving award, that used similar techniques and measures to quantify marijuana impaired automobile driving. We will be utilizing tasks and assessments that were shown to be strong indicators for cognitive and driving impairment in our NHTSA study.


Clinical Trial Description

The proposed study was based upon a careful and thorough review of the scientific literature describing CNB effects on cognitive test performance and driving, as well as current state-of-knowledge on the sensitivity of biological assays for identifying recent CNB use. The study will carefully characterize the persistence of CNB's acute effects on cognitive test performance and driving over a several-hour time span. This will allow us to identify the point at which any effects of CNB intoxication driving-related cognitive tests, and driving performance cannot be distinguished from normal, i.e., the first step towards establishing standards for legal and social policy. The data obtained from simulated driving, cognitive tests, and biological assays of THC will be used in analyses aimed at identifying what tests or combination of tests predict both recent use and driving impairment risk. This study will consist of 2 days (screening visit and dose visit). In a non-randomized, single blinded study, we will dose participants with placebo and high THC marijuana, about an hour apart, using paced inhalation through a vaporizer, an efficient means of delivering a standard THC dose. Participants will be told that the order they receive the doses will be random but they will always receive the placebo first, followed by the high dose. This will allow for standardization across all subjects and comparative values between placebo and drug. After inhaling the placebo dose, participants will be asked to complete one round of cognitive testing and a shortened version of the driving simulator (10 mins vs 30 mins). Approximately one hour post placebo dose, subjects will be administered high THC marijuana. Following this dosing, we will assess impairment through cognitive testing as well as a simulated driving test and neuropsychological tests. Samples of blood will also be collected at multiple time points throughout the study visits to be measured for THC concentration and its metabolites. This allows clarification between the relationship of impairment, as well as subjective and objective intoxication, and levels of THC and it's metabolites in the users system. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05115513
Study type Interventional
Source Yale University
Contact Suyash Adhikari, B.S
Phone 860-545-7106
Email [email protected]
Status Not yet recruiting
Phase Phase 1
Start date December 2021
Completion date December 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Recruiting NCT04587700 - Analgesic Consumption in Chronic Marijuana Users Following Orthopedic Trauma Surgery
Recruiting NCT03560934 - Tetrahydrocannabinol (THC) and Sleep Early Phase 1
Recruiting NCT04495725 - Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain N/A
Recruiting NCT04308148 - Does Medical Cannabis Reduce Opioid Use in Adults With Pain
Completed NCT03401333 - Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use N/A
Completed NCT04851392 - Do Adolescents and Adults Differ in Their Acute Response to Cannabis? N/A
Recruiting NCT03699540 - Marijuana Effects on Simulated Driving Performance Phase 1
Completed NCT02983773 - Marijuana's Impact on Alcohol Motivation and Consumption Phase 2
Active, not recruiting NCT02102113 - Probing the Cannabinoid System in Individuals With a Family History of Psychosis N/A
Not yet recruiting NCT05116527 - THC Memory & Reward Learning Pilot Phase 1/Phase 2
Recruiting NCT04866004 - Contingency Management for Cannabis Use for Persons With HIV N/A
Completed NCT02744118 - Helping Eliminate Marijuana Use Through Pediatric Practice N/A